Cell-based Assay Market Research Report by Offerings (Consumables, Instruments, and Services), by Application (Basic Research and Drug Discovery), by End User, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026

Cell-based Assay Market Research Report by Offerings (Consumables, Instruments, and Services), by Application (Basic Research and Drug Discovery), by End User, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

The Global Cell-based Assay Market size was estimated at USD 13.53 billion in 2020 and expected to reach USD 14.46 billion in 2021, at a CAGR 7.25% to reach USD 20.59 billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Cell-based Assay to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Offerings, the market was studied across Consumables, Instruments, and Services. The Consumables is further studied across Assay Kits, Cell Lines, Microplates, Probes & Labels, and Reagents.

Based on Application, the market was studied across Basic Research and Drug Discovery. The Drug Discovery is further studied across Pharmacodynamic Studies, Pharmacokinetic Studies, and Toxicity Studies.

Based on End User, the market was studied across Academic & Government Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell-based Assay Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell-based Assay Market, including Becton, Dickinson and Company, Cell Biolabs, Inc., Cell Signaling Technology, Inc., Charles River Laboratories, Inc., Cisbio, Danaher Corporation, GE Healthcare, Lonza Group Ltd., Merck KGaA, Perkinelmer, Inc., Promega Corporation, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cell-based Assay Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell-based Assay Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell-based Assay Market?
4. What is the competitive strategic window for opportunities in the Global Cell-based Assay Market?
5. What are the technology trends and regulatory frameworks in the Global Cell-based Assay Market?
6. What is the market share of the leading vendors in the Global Cell-based Assay Market?
7. What modes and strategic moves are considered suitable for entering the Global Cell-based Assay Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Prevalence of cardiovascular & infectious disease, diabetes, and cancer worldwide
5.2.2. Awareness regarding advantages of cell-based assays over traditional treatments
5.2.3. Rising worldwide demand for novel drugs and treatments
5.3. Restraints
5.3.1. Limited skilled professionals
5.4. Opportunities
5.4.1. Potential in emerging economies
5.4.2. Rising use of cell-based assays in various ultra-high throughput screening
5.4.3. Growing number of in-vitro drug studies based on cell-based assays
5.5. Challenges
5.5.1. Unfavourable regulatory framework
6. Cell-based Assay Market, by Offerings
6.1. Introduction
6.2. Consumables
6.2.1. Assay Kits
6.2.2. Cell Lines
6.2.3. Microplates
6.2.4. Probes & Labels
6.2.5. Reagents
6.3. Instruments
6.4. Services
7. Cell-based Assay Market, by Application
7.1. Introduction
7.2. Basic Research
7.3. Drug Discovery
7.3.1. Pharmacodynamic Studies
7.3.2. Pharmacokinetic Studies
7.3.3. Toxicity Studies
8. Cell-based Assay Market, by End User
8.1. Introduction
8.2. Academic & Government Institutes
8.3. Contract Research Organizations
8.4. Pharmaceutical & Biotechnology Companies
9. Americas Cell-based Assay Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cell-based Assay Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Cell-based Assay Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Becton, Dickinson and Company
13.2. Cell Biolabs, Inc.
13.3. Cell Signaling Technology, Inc.
13.4. Charles River Laboratories, Inc.
13.5. Cisbio
13.6. Danaher Corporation
13.7. GE Healthcare
13.8. Lonza Group Ltd.
13.9. Merck KGaA
13.10. Perkinelmer, Inc.
13.11. Promega Corporation
13.12. Thermo Fisher Scientific Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CELL-BASED ASSAY MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 3. GLOBAL CELL-BASED ASSAY MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2020 VS 2026 (%)
FIGURE 5. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2020 VS 2026 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2026
FIGURE 7. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2026 (USD BILLION)
FIGURE 8. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 9. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, 2018-2026 (USD BILLION)
FIGURE 10. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 11. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, 2018-2026 (USD BILLION)
FIGURE 12. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 13. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, 2018-2026 (USD BILLION)
FIGURE 18. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 19. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2026 (USD BILLION)
FIGURE 20. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 21. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY SERVICES, 2018-2026 (USD BILLION)
FIGURE 22. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 23. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 24. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2026
FIGURE 26. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, 2018-2026 (USD BILLION)
FIGURE 27. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 28. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2026 (USD BILLION)
FIGURE 29. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 30. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, 2018-2026 (USD BILLION)
FIGURE 31. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 32. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, 2018-2026 (USD BILLION)
FIGURE 33. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 34. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 37. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END USER, 2026
FIGURE 39. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, 2018-2026 (USD BILLION)
FIGURE 40. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 41. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2026 (USD BILLION)
FIGURE 42. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 43. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2026 (USD BILLION)
FIGURE 44. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 45. AMERICAS CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. ARGENTINA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. BRAZIL CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. CANADA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. MEXICO CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. UNITED STATES CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. CHINA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. INDIA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. INDONESIA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. JAPAN CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. MALAYSIA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. SINGAPORE CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. TAIWAN CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. THAILAND CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. FRANCE CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. GERMANY CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. ITALY CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 68. QATAR CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 69. RUSSIA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 70. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 71. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 72. SPAIN CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 73. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 74. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 75. GLOBAL CELL-BASED ASSAY MARKET: FPNV POSITIONING MATRIX
FIGURE 76. GLOBAL CELL-BASED ASSAY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CELL-BASED ASSAY MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CELL-BASED ASSAY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 20. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018-2026 (USD BILLION)
TABLE 21. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2026 (USD BILLION)
TABLE 22. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 23. AMERICAS CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. ARGENTINA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. BRAZIL CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. CANADA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. MEXICO CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. UNITED STATES CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. CHINA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. INDIA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. INDONESIA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. JAPAN CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. MALAYSIA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. SINGAPORE CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. TAIWAN CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. THAILAND CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. FRANCE CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. GERMANY CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. ITALY CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. QATAR CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. RUSSIA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 49. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 50. SPAIN CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 51. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 52. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 53. GLOBAL CELL-BASED ASSAY MARKET: SCORES
TABLE 54. GLOBAL CELL-BASED ASSAY MARKET: BUSINESS STRATEGY
TABLE 55. GLOBAL CELL-BASED ASSAY MARKET: PRODUCT SATISFACTION
TABLE 56. GLOBAL CELL-BASED ASSAY MARKET: RANKING
TABLE 57. GLOBAL CELL-BASED ASSAY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 58. GLOBAL CELL-BASED ASSAY MARKET: MERGER & ACQUISITION
TABLE 59. GLOBAL CELL-BASED ASSAY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 60. GLOBAL CELL-BASED ASSAY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 61. GLOBAL CELL-BASED ASSAY MARKET: INVESTMENT & FUNDING
TABLE 62. GLOBAL CELL-BASED ASSAY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 63. GLOBAL CELL-BASED ASSAY MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook